BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 30711674)

  • 1. Gray and white matter changes in presymptomatic genetic frontotemporal dementia: a longitudinal MRI study.
    Panman JL; Jiskoot LC; Bouts MJRJ; Meeter LHH; van der Ende EL; Poos JM; Feis RA; Kievit AJA; van Minkelen R; Dopper EGP; Rombouts SARB; van Swieten JC; Papma JM
    Neurobiol Aging; 2019 Apr; 76():115-124. PubMed ID: 30711674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal multimodal MRI as prognostic and diagnostic biomarker in presymptomatic familial frontotemporal dementia.
    Jiskoot LC; Panman JL; Meeter LH; Dopper EGP; Donker Kaat L; Franzen S; van der Ende EL; van Minkelen R; Rombouts SARB; Papma JM; van Swieten JC
    Brain; 2019 Jan; 142(1):193-208. PubMed ID: 30508042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognition and gray and white matter characteristics of presymptomatic
    Papma JM; Jiskoot LC; Panman JL; Dopper EG; den Heijer T; Donker Kaat L; Pijnenburg YAL; Meeter LH; van Minkelen R; Rombouts SARB; van Swieten JC
    Neurology; 2017 Sep; 89(12):1256-1264. PubMed ID: 28855404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of gray matter atrophy in genetic frontotemporal dementia: results from the GENFI study.
    Cash DM; Bocchetta M; Thomas DL; Dick KM; van Swieten JC; Borroni B; Galimberti D; Masellis M; Tartaglia MC; Rowe JB; Graff C; Tagliavini F; Frisoni GB; Laforce R; Finger E; de Mendonça A; Sorbi S; Rossor MN; Ourselin S; Rohrer JD;
    Neurobiol Aging; 2018 Feb; 62():191-196. PubMed ID: 29172163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal structural gray matter and white matter MRI changes in presymptomatic progranulin mutation carriers.
    Olm CA; McMillan CT; Irwin DJ; Van Deerlin VM; Cook PA; Gee JC; Grossman M
    Neuroimage Clin; 2018; 19():497-506. PubMed ID: 29984158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. White matter hyperintensities in progranulin-associated frontotemporal dementia: A longitudinal GENFI study.
    Sudre CH; Bocchetta M; Heller C; Convery R; Neason M; Moore KM; Cash DM; Thomas DL; Woollacott IOC; Foiani M; Heslegrave A; Shafei R; Greaves C; van Swieten J; Moreno F; Sanchez-Valle R; Borroni B; Laforce R; Masellis M; Tartaglia MC; Graff C; Galimberti D; Rowe JB; Finger E; Synofzik M; Vandenberghe R; de Mendonça A; Tagliavini F; Santana I; Ducharme S; Butler C; Gerhard A; Levin J; Danek A; Frisoni GB; Sorbi S; Otto M; Zetterberg H; Ourselin S; Cardoso MJ; Rohrer JD;
    Neuroimage Clin; 2019; 24():102077. PubMed ID: 31835286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multimodal MRI of grey matter, white matter, and functional connectivity in cognitively healthy mutation carriers at risk for frontotemporal dementia and Alzheimer's disease.
    Feis RA; Bouts MJRJ; Dopper EGP; Filippini N; Heise V; Trachtenberg AJ; van Swieten JC; van Buchem MA; van der Grond J; Mackay CE; Rombouts SARB
    BMC Neurol; 2019 Dec; 19(1):343. PubMed ID: 31881858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rates of Brain Atrophy Across Disease Stages in Familial Frontotemporal Dementia Associated With MAPT, GRN, and C9orf72 Pathogenic Variants.
    Staffaroni AM; Goh SM; Cobigo Y; Ong E; Lee SE; Casaletto KB; Wolf A; Forsberg LK; Ghoshal N; Graff-Radford NR; Grossman M; Heuer HW; Hsiung GR; Kantarci K; Knopman DS; Kremers WK; Mackenzie IR; Miller BL; Pedraza O; Rascovsky K; Tartaglia MC; Wszolek ZK; Kramer JH; Kornak J; Boeve BF; Boxer AL; Rosen HJ;
    JAMA Netw Open; 2020 Oct; 3(10):e2022847. PubMed ID: 33112398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Network degeneration and dysfunction in presymptomatic
    Lee SE; Sias AC; Mandelli ML; Brown JA; Brown AB; Khazenzon AM; Vidovszky AA; Zanto TP; Karydas AM; Pribadi M; Dokuru D; Coppola G; Geschwind DH; Rademakers R; Gorno-Tempini ML; Rosen HJ; Miller BL; Seeley WW
    Neuroimage Clin; 2017; 14():286-297. PubMed ID: 28337409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct Neuroanatomical Correlates of Neuropsychiatric Symptoms in the Three Main Forms of Genetic Frontotemporal Dementia in the GENFI Cohort.
    Sellami L; Bocchetta M; Masellis M; Cash DM; Dick KM; van Swieten J; Borroni B; Galimberti D; Tartaglia MC; Rowe JB; Graff C; Tagliavini F; Frisoni G; Finger E; de Mendonça A; Sorbi S; Warren JD; Rohrer JD; Laforce R;
    J Alzheimers Dis; 2018; 65(1):147-163. PubMed ID: 30010122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral perfusion changes in presymptomatic genetic frontotemporal dementia: a GENFI study.
    Mutsaerts HJMM; Mirza SS; Petr J; Thomas DL; Cash DM; Bocchetta M; de Vita E; Metcalfe AWS; Shirzadi Z; Robertson AD; Tartaglia MC; Mitchell SB; Black SE; Freedman M; Tang-Wai D; Keren R; Rogaeva E; van Swieten J; Laforce R; Tagliavini F; Borroni B; Galimberti D; Rowe JB; Graff C; Frisoni GB; Finger E; Sorbi S; de Mendonça A; Rohrer JD; MacIntosh BJ; Masellis M;
    Brain; 2019 Apr; 142(4):1108-1120. PubMed ID: 30847466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gray matter changes in asymptomatic
    Popuri K; Dowds E; Beg MF; Balachandar R; Bhalla M; Jacova C; Buller A; Slack P; Sengdy P; Rademakers R; Wittenberg D; Feldman HH; Mackenzie IR; Hsiung GR
    Neuroimage Clin; 2018; 18():591-598. PubMed ID: 29845007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. White matter hyperintensities are seen only in
    Sudre CH; Bocchetta M; Cash D; Thomas DL; Woollacott I; Dick KM; van Swieten J; Borroni B; Galimberti D; Masellis M; Tartaglia MC; Rowe JB; Graff C; Tagliavini F; Frisoni G; Laforce R; Finger E; de Mendonça A; Sorbi S; Ourselin S; Cardoso MJ; Rohrer JD;
    Neuroimage Clin; 2017; 15():171-180. PubMed ID: 28529873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Education modulates brain maintenance in presymptomatic frontotemporal dementia.
    Gazzina S; Grassi M; Premi E; Cosseddu M; Alberici A; Archetti S; Gasparotti R; Van Swieten J; Galimberti D; Sanchez-Valle R; Laforce RJ; Moreno F; Synofzik M; Graff C; Masellis M; Tartaglia MC; Rowe JB; Vandenberghe R; Finger E; Tagliavini F; de Mendonça A; Santana I; Butler CR; Ducharme S; Gerhard A; Danek A; Levin J; Otto M; Frisoni G; Sorbi S; Padovani A; Rohrer JD; Borroni B;
    J Neurol Neurosurg Psychiatry; 2019 Oct; 90(10):1124-1130. PubMed ID: 31182509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral blood flow in presymptomatic MAPT and GRN mutation carriers: A longitudinal arterial spin labeling study.
    Dopper EG; Chalos V; Ghariq E; den Heijer T; Hafkemeijer A; Jiskoot LC; de Koning I; Seelaar H; van Minkelen R; van Osch MJ; Rombouts SA; van Swieten JC
    Neuroimage Clin; 2016; 12():460-5. PubMed ID: 27625986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tracking white matter degeneration in asymptomatic and symptomatic MAPT mutation carriers.
    Chen Q; Boeve BF; Schwarz CG; Reid R; Tosakulwong N; Lesnick TG; Bove J; Brannelly P; Brushaber D; Coppola G; Dheel C; Dickerson BC; Dickinson S; Faber K; Fields J; Fong J; Foroud T; Forsberg L; Gavrilova RH; Gearhart D; Ghoshal N; Goldman J; Graff-Radford J; Graff-Radford NR; Grossman M; Haley D; Heuer HW; Hsiung GR; Huey E; Irwin DJ; Jack CR; Jones DT; Jones L; Karydas AM; Knopman DS; Kornak J; Kramer J; Kremers W; Kukull WA; Lapid M; Lucente D; Lungu C; Mackenzie IRA; Manoochehri M; McGinnis S; Miller BL; Pearlman R; Petrucelli L; Potter M; Rademakers R; Ramos EM; Rankin KP; Rascovsky K; Sengdy P; Shaw L; Syrjanen J; Tatton N; Taylor J; Toga AW; Trojanowski J; Weintraub S; Wong B; Boxer AL; Rosen H; Wszolek Z; Kantarci K;
    Neurobiol Aging; 2019 Nov; 83():54-62. PubMed ID: 31585367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multimodal MRI-based classification signature emerges just prior to symptom onset in frontotemporal dementia mutation carriers.
    Feis RA; Bouts MJRJ; de Vos F; Schouten TM; Panman JL; Jiskoot LC; Dopper EGP; van der Grond J; van Swieten JC; Rombouts SARB
    J Neurol Neurosurg Psychiatry; 2019 Nov; 90(11):1207-1214. PubMed ID: 31203211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-subject classification of presymptomatic frontotemporal dementia mutation carriers using multimodal MRI.
    Feis RA; Bouts MJRJ; Panman JL; Jiskoot LC; Dopper EGP; Schouten TM; de Vos F; van der Grond J; van Swieten JC; Rombouts SARB
    Neuroimage Clin; 2018; 20():188-196. PubMed ID: 30094168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presymptomatic white matter integrity loss in familial frontotemporal dementia in the GENFI cohort: A cross-sectional diffusion tensor imaging study.
    Jiskoot LC; Bocchetta M; Nicholas JM; Cash DM; Thomas D; Modat M; Ourselin S; Rombouts SARB; Dopper EGP; Meeter LH; Panman JL; van Minkelen R; van der Ende EL; Donker Kaat L; Pijnenburg YAL; Borroni B; Galimberti D; Masellis M; Tartaglia MC; Rowe J; Graff C; Tagliavini F; Frisoni GB; Laforce R; Finger E; de Mendonça A; Sorbi S; ; Papma JM; van Swieten JC; Rohrer JD
    Ann Clin Transl Neurol; 2018 Sep; 5(9):1025-1036. PubMed ID: 30250860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ventricular volume expansion in presymptomatic genetic frontotemporal dementia.
    Tavares TP; Mitchell DGV; Coleman K; Shoesmith C; Bartha R; Cash DM; Moore KM; van Swieten J; Borroni B; Galimberti D; Tartaglia MC; Rowe J; Graff C; Tagliavini F; Frisoni G; Cappa S; Laforce R; de Mendonça A; Sorbi S; Wallstrom G; Masellis M; Rohrer JD; Finger EC;
    Neurology; 2019 Oct; 93(18):e1699-e1706. PubMed ID: 31578297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.